Although the exact role of the SphK/S1P system in regulating the pathogenesis of IBD still remains to be fully elucidated, present findings reinforce the interest in novel molecular pathways that may represent an attractive target for therapeutic interventions in IBD. This evidence concerns the gene MBTPS1 and inflammatory bowel disease.